BioNTech prepping for major upside to 138

Inv Head and Shoulders seems to be forming on BioNTech company listed on the Nasdaq.

We might have a consolidation period for the final shoulder to form before it breaks up and out of it.
There is also a solid uptrend, which the price continues to make higher lows.

With the price staying above the 200MA will help the bullish momentum send it to the first target of $138.36.

Let's see how it plays out as it's still a bit early before jumping in.